uPAR-CAR-T cell therapy

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameuPAR-CAR-T cell therapy
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionUrokinase plasminogen activator modulators
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsMultiple Chronic ConditionsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPeking University
China Registration ClassN/A

Develop Information

Active CompaniesPeking University
Inactive CompaniesN/A
Active IndicationsMultiple Chronic ConditionsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A